| |
Latest 10 SEC filings (by transaction date) for SRRK within the last 6 months | |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 21/25 | Jan 16/25 | Backstrom Jay T. | Direct Ownership | Common Stock | S - Open market or private sale | -22,308 | $44.20 |
Jan 21/25 | Jan 16/25 | Marantz Jing L. | Direct Ownership | Common Stock | S - Open market or private sale | -5,655 | $44.20 |
Jan 21/25 | Jan 16/25 | Sacco Tracey | Direct Ownership | Common Stock | S - Open market or private sale | -3,890 | $44.20 |
Jan 21/25 | Jan 16/25 | Qatanani Mo | Direct Ownership | Common Stock | S - Open market or private sale | -7,347 | $44.20 |
Jan 21/25 | Jan 16/25 | Parlavecchio Caryn | Direct Ownership | Common Stock | S - Open market or private sale | -6,434 | $44.20 |
Jan 21/25 | Jan 16/25 | Myles Edward H | Direct Ownership | Common Stock | S - Open market or private sale | -12,539 | $44.20 |
Jan 21/25 | Jan 16/25 | Ho Junlin | Direct Ownership | Common Stock | S - Open market or private sale | -9,039 | $44.20 |
Dec 12/24 | Dec 10/24 | Invus Public Equities, L.P. | Direct Ownership | Common Stock | S - Open market or private sale | -1,600,000 | $41.65 |
Nov 26/24 | Nov 25/24 | Marantz Jing L. | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -6,375 | |
Nov 26/24 | Nov 25/24 | Marantz Jing L. | Direct Ownership | Common Stock | S - Open market or private sale | -200 | $40.72 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for SRRK within the last 6 months | |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 21/25 | Jan 16/25 | Backstrom Jay T. | Direct Ownership | Common Stock | S - Open market or private sale | -22,308 | $44.20 |
Jan 21/25 | Jan 16/25 | Marantz Jing L. | Direct Ownership | Common Stock | S - Open market or private sale | -5,655 | $44.20 |
Jan 21/25 | Jan 16/25 | Sacco Tracey | Direct Ownership | Common Stock | S - Open market or private sale | -3,890 | $44.20 |
Jan 21/25 | Jan 16/25 | Qatanani Mo | Direct Ownership | Common Stock | S - Open market or private sale | -7,347 | $44.20 |
Jan 21/25 | Jan 16/25 | Parlavecchio Caryn | Direct Ownership | Common Stock | S - Open market or private sale | -6,434 | $44.20 |
Jan 21/25 | Jan 16/25 | Myles Edward H | Direct Ownership | Common Stock | S - Open market or private sale | -12,539 | $44.20 |
Jan 21/25 | Jan 16/25 | Ho Junlin | Direct Ownership | Common Stock | S - Open market or private sale | -9,039 | $44.20 |
Dec 12/24 | Dec 10/24 | Invus Public Equities, L.P. | Direct Ownership | Common Stock | S - Open market or private sale | -1,600,000 | $41.65 |
Nov 27/24 | Nov 25/24 | Invus Public Equities, L.P. | Direct Ownership | Common Stock | S - Open market or private sale | -149 | $40.98 |
Nov 27/24 | Nov 25/24 | Invus Public Equities, L.P. | Direct Ownership | Common Stock | S - Open market or private sale | -30,683 | $40.14 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Viking Therapeutics (OQ:VKTX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Insmed (OQ:INSM) |